A significantly increased proportion of tumors displaying elevated KLK5 mRNA expression (p = 0.041) was observed in the patient group with post-operative residual tumor (44%, 29/66), compared to the tumor-free group (27%, 19/70). This evidence concerns the gene KLK5 and neoplasm.